Hugh Wilson

437 total citations
12 papers, 334 citations indexed

About

Hugh Wilson is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pharmacology. According to data from OpenAlex, Hugh Wilson has authored 12 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 4 papers in Pharmacology. Recurrent topics in Hugh Wilson's work include Heart Failure Treatment and Management (3 papers), Neurological and metabolic disorders (2 papers) and Pharmacology and Obesity Treatment (2 papers). Hugh Wilson is often cited by papers focused on Heart Failure Treatment and Management (3 papers), Neurological and metabolic disorders (2 papers) and Pharmacology and Obesity Treatment (2 papers). Hugh Wilson collaborates with scholars based in United States and United Kingdom. Hugh Wilson's co-authors include Mario L. Rocci, James W. Fasules, J E Henson, Adam Tucker, K.R. Stenmark, Dallas M. Hyde, N. F. Voelkel, J. T. Reeves, Karl T. Weber and Mariell J. Likoff and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Applied Physiology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Hugh Wilson

12 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hugh Wilson United States	9	144	127	60	58	39	12	334
Luis C. Ramirez United States	9	127 0.9×	95 0.7×	84 1.4×	26 0.4×	51 1.3×	13	416
Michel Staroukine Belgium	13	152 1.1×	56 0.4×	44 0.7×	55 0.9×	69 1.8×	28	380
S Yeung Australia	8	77 0.5×	50 0.4×	50 0.8×	48 0.8×	39 1.0×	9	365
K Maekawa Japan	7	235 1.6×	96 0.8×	53 0.9×	10 0.2×	45 1.2×	20	431
R. Green United Kingdom	10	100 0.7×	111 0.9×	22 0.4×	103 1.8×	29 0.7×	12	332
Sheldon H. Steiner United States	8	39 0.3×	64 0.5×	74 1.2×	52 0.9×	52 1.3×	18	319
E. Cran Australia	7	202 1.4×	54 0.4×	19 0.3×	107 1.8×	34 0.9×	9	410
N. Hiatt United States	11	61 0.4×	133 1.0×	91 1.5×	74 1.3×	40 1.0×	43	385
Arthur M. Melkumyants Russia	11	141 1.0×	57 0.4×	73 1.2×	47 0.8×	123 3.2×	23	338
Luca De Siati Italy	7	215 1.5×	70 0.6×	29 0.5×	30 0.5×	122 3.1×	10	350

Countries citing papers authored by Hugh Wilson

Since Specialization

Citations

This map shows the geographic impact of Hugh Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh Wilson more than expected).

Fields of papers citing papers by Hugh Wilson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh Wilson. The network helps show where Hugh Wilson may publish in the future.

Co-authorship network of co-authors of Hugh Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh Wilson. A scholar is included among the top collaborators of Hugh Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh Wilson. Hugh Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Wilson, Hugh, et al.. (2011). Cannabinoid hyperemesis. Emergency Medicine Journal. 29(1). 67–69. 6 indexed citations

2.

Wild, K. von & Hugh Wilson. (2010). Cannabinoid hyperemesis. BMJ Case Reports. 2010. bcr0120102605–bcr0120102605. 12 indexed citations

3.

Papadopoulos, Chris & Hugh Wilson. (2008). Capecitabine-associated coronary vasospasm: a case report. Emergency Medicine Journal. 25(5). 307–309. 9 indexed citations

4.

Rocci, Mario L. & Hugh Wilson. (1987). The Pharmacokinetics and Pharmacodynamics of Newer Inotropic Agents. Clinical Pharmacokinetics. 13(2). 91–109. 29 indexed citations

5.

Wilson, Hugh, et al.. (1987). Pharmacokinetics and hemodynamics of amrinone in patients with chronic cardiac failure of diverse etiology.. PubMed. 56(1). 3–19. 10 indexed citations

6.

Stenmark, K.R., James W. Fasules, Dallas M. Hyde, et al.. (1987). Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 m. Journal of Applied Physiology. 62(2). 821–830. 163 indexed citations

7.

Larijani, Ghassem E., et al.. (1985). The pharmacokinetics of amrinone at three dose levels in the rabbit.. Pharmaceutical Research. 2(4). 176–177. 2 indexed citations

8.

Hayes, J S, et al.. (1985). Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.. Journal of Pharmacology and Experimental Therapeutics. 233(2). 318–326. 16 indexed citations

9.

Likoff, Mariell J., et al.. (1985). Milrinone in the treatment of chronic cardiac failure: A controlled trial. American Heart Journal. 110(5). 1035–1042. 20 indexed citations

10.

Likoff, Mariell J., Karl T. Weber, Joseph S. Janicki, et al.. (1984). Amrinone in the treatment of chronic cardiac failure. Journal of the American College of Cardiology. 3(5). 1282–1290. 44 indexed citations

11.

Barnes, William E., et al.. (1956). Tuberculosis of the Myocardium A Case Report. Diseases of the Chest. 29(1). 96–101. 5 indexed citations

12.

Jd, Hardy, et al.. (1954). Cardiac output: a clinical comparison of the direct Fick, dye, and ballistocardiographic methods.. PubMed. 35(1). 22–9. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact